Evidence map›Paper›PMID 32651790›Full record

ArticleEnvironmental science and pollution research international2020

Extremely low-frequency electromagnetic field induces a change in proliferative capacity and redox homeostasis of human lung fibroblast cell line MRC-5.

Maida H Lekovic, Nerkesa E Drekovic, Nihat Dz Granica, Elvis H Mahmutovic, Natasa Z Djordjevic

Abstract read
PubMed Publisher
In one paragraph

Article in Environmental science and pollution research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Maida H LekovicDepartment of Biomedical Sciences, State University of Novi Pazar, Vuka Karadzica bb, Novi Pazar, 36300, Serbia.
Nerkesa E DrekovicDepartment of Biomedical Sciences, State University of Novi Pazar, Vuka Karadzica bb, Novi Pazar, 36300, Serbia.
Nihat Dz GranicaDepartment of Biomedical Sciences, State University of Novi Pazar, Vuka Karadzica bb, Novi Pazar, 36300, Serbia.
Elvis H MahmutovicDepartment of Biomedical Sciences, State University of Novi Pazar, Vuka Karadzica bb, Novi Pazar, 36300, Serbia.
Natasa Z DjordjevicDepartment of Biomedical Sciences, State University of Novi Pazar, Vuka Karadzica bb, Novi Pazar, 36300, Serbia. natasadj@np.ac.rs.ORCID http://orcid.org/0000-0002-1100-5689
State University of Novi Pazar · RS

Funding

Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja 173041
6 · The paper itself

Abstract

Numerous studies have shown that extremely low-frequency electromagnetic field (ELF-EMF) by modulating oxidative-antioxidative balance in the cells achieved beneficial and harmful effects on living organisms. The aim of this study was to research changes of both proliferative capacity and redox homeostasis of human lung fibroblast cell line MRC-5 during exposure to ELF-EMF (50 Hz). The human lung fibroblast cell line MRC-5 were exposed to ELF-EMF once a day in duration of 1 h during 24 h (1 treatment 1 h/day), 48 h (2 treatments 1 h/day), 72 h (3 treatments 1 h/day), and 7 days (7 treatments 1 h/day). After 24 h of the last treatment, the proliferative capacity of the cells and the concentrations and activities of the components of the oxidative/antioxidative system were determined: superoxide anion (O

Indexed as

Electromagnetic FieldsHydrogen PeroxideCell LineFibroblastsHomeostasisHumansOxidation-ReductionHydrogen PeroxideCell proliferationElectromagnetic fieldHuman lung fibroblastsRedox homeostasis

Identifiers

PMID32651790
OpenAlexW3041832895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.